M&A Deal Summary

Merck Acquires Versum Materials

On January 28, 2019, Merck acquired chemicals company Versum Materials for 5.8B EUR

Acquisition Highlights
  • This is Merck’s 4th transaction in the Chemicals sector.
  • This is Merck’s 3rd largest (disclosed) transaction.
  • This is Merck’s 8th transaction in the United States.
  • This is Merck’s 2nd transaction in Pennsylvania.

M&A Deal Summary
Date 2019-01-28
Target Versum Materials
Sector Chemicals
Buyer(s) Merck
Deal Type Add-on Acquisition
Deal Value 5.8B EUR
Advisor(s) Lazard Ltd.
Citizens Capital Markets (Financial)
Simpson Thacher & Bartlett (Legal)

Target

Versum Materials

Allentown, Pennsylvania, United States
Versum Materials, Inc. is an electronic materials company providing high-purity chemicals and gases, delivery systems, services, and materials expertise to meet the evolving needs of the global semiconductor and display industries. Versum Materials Inc. is based in Allentown, Pennsylvania.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Merck

Darmstadt, Germany
Category Company
Founded 1668
Sector Diversified
Employees64,011
Revenue 21.0B EUR (2023)
DESCRIPTION

Merck is a science and technology company in healthcare, life science, and performance materials. Merck develops technologies that improve and enhance life from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.

DEAL STATS #
Overall 19 of 24
Sector (Chemicals) 4 of 4
Type (Add-on Acquisition) 15 of 20
State (Pennsylvania) 2 of 2
Country (United States) 8 of 10
Year (2019) 1 of 2
Size (of disclosed) 3 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-18 Merck KGaA - Flow Cytometry Portfolio

Darmstadt, Germany

Merck KGaA - Flow Cytometry Portfolio includes Amnis, the market-leading family of imaging flow cytometry products for cell-based analysis, as well as their Guava portfolio of products, which are economical, high-performance systems based on microcapillary technologies.

Sell €63M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-06 Intermolecular

San Jose, California, United States

Intermolecular, Inc. is a provider of a range of advanced materials innovation to industries, including semiconductors, consumer electronics, automotive, and aerospace. Intermolecular was founded in 2004 and is based in San Jose, California.

Buy $62M
Mergr

Product

Company

Legal